TNF receptor associated factors in cytokine signaling

Cytokine and Growth Factor Reviews

Volumn 10, Issue 1, 1999, Pages 15-26

  Wajant, H ^a   Grell, M ^a   Scheurich, P ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CYTOKINE; EBV-ASSOCIATED MEMBRANE ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); RECEPTOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL; CAENORHABDITIS ELEGANS; CELL DEATH; CELL SURVIVAL; CYTOKINE PRODUCTION; ENZYME INDUCTION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MULTIGENE FAMILY; NONHUMAN; PHYSIOLOGY; SEQUENCE HOMOLOGY; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL;

AMINO ACID SEQUENCE; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CYTOKINES; HUMANS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; RECEPTORS, TUMOR NECROSIS FACTOR; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS;

ANIMALIA; CAENORHABDITIS ELEGANS; MURINAE;

EID: 0033103894     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(98)00023-9     Document Type: Short Survey

References (114)

1. Ware C.F., Santee S., Glass A. Tumor necrosis factor-related ligands and receptors. Thomson A. The Cytokine Handbook. 1989;549-592 Academic Press, London.
2. Itoh N., Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem. 268:1993;10932-10937.
3. Tartaglia L.A., Ayres T.M., Wong G.H., Goeddel D.V. A novel domain within the 55 kD TNF receptor signals cell death. Cell. 74:1993;845-853.
4. Schulze-Osthoff K., Ferrari D., Los M., Wesselborg S., Peter M.E. Apoptosis signaling by death receptors. Eur J Biochem. 254:1998;439-459.
5. Martin D.A., Siegel R.M., Zheng L.X., Lenardo M.J. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACH-α-1) death signal. J Biol Chem. 273:1998;4345-4349.
6. Yang X.L., Chang H.Y., Baltimore D. Autoproteolytic activation of pro-caspases by oligomerization. Mol Cell. 1:1998;319-325.
7. Hsu H., Shu H.B., Pan M.G., Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:1996;299-308.
8. Chinnaiyan A.M., O'Rourke K., Yu G.L., Lyons R.H., Garg M., Duan D.R., Xing L., Gentz R., Ni J., Dixit V.M. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science. 274:1996;990-992.
9. Rothe M., Wong S.C., Henzel W.J., Goeddel D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:1994;681-692.
10. Wajant H, Mühlenbeck F, Scheurich P, Identification of a TRAF gene in Caenorhabditis elegans, J Mol Evol 1998; (in press).
11. Freemont P.S. The RING finger. A novel protein sequence motif related to the zink finger. Ann NY Acad Sci. 684:1993;174-192.
12. Cheng G., Cleary A.M., Ye Z.S., Hong D.I., Lederman S., Baltimore D. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science. 267:1995;1494-1498.
13. Lee S.Y., Lee S.Y., Kandala G., Liou M.L., Liou H.C., Choi Y. CD30/TNF receptor-associated factor interaction: NF-κ B activation and binding specificity. Proc Natl Acad Sci USA. 93:1996;9699-9703.
14. Takeuchi M., Rothe M., Goeddel D.V. Anatomy of TRAF2. Distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. J Biol Chem. 271:1996;19935-19942.
15. Force W.R., Cheung T.C., Ware C.F. Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-β receptor. J Biol Chem. 272:1997;30835-30840.
16. Boucher L.M., Marengere L.E.M., Lu Y., Thukral S., Mak T.W. Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily. Biochem Biophys Res Commun. 233:1997;592-600.
17. Gedrich R.W., Gilfillan M.C., Duckett C.S., Van Dongen J.L., Thompson C.B. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J Biol Chem. 271:1996;12852-12858.
18. Darnay B.G., Haridas V., Ni J., Moore P.A., Aggarwal B.B. Characterization of the intracellular domain of receptor activator of NF-κ-B (RANK) - interaction with tumor necrosis factor receptor-associated factors and activation of NF-κ-B and c-Jun N-terminal kinase. J Biol Chem. 273:1998;20551-20555.
19. Devergne O., Hatzivassiliou E., Izumi K.M., Kaye K.M., Kleijnen M.F., Kieff E., Mosialos G. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation - role in NF-κ-B activation. Mol Cell Biol. 16:1996;7098-7108.
20. Devergne O., McFarland E.C., Mosialos G., Izumi K.M., Ware C.F., Kieff E. Role of the TRAF binding site and NF-κ-B activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J Virol. 72:1998;7900-7908.
21. Hsu H.L., Solovyev I., Colombero A., Elliott R., Kelley M., Boyle W.J. ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J Biol Chem. 272:1997;13471-13474.
22. Arch R.H., Thompson C.B. 4-1BB and OX40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κ-B. Mol Cell Biol. 18:1998;558-565.
23. Shu H.B., Takeuchi M., Goeddel D.V. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA. 93:1996;13973-13978.
24. Liu Z.G., Hsu H.L., Goeddel D.V., Karin M. Dissection of TNF receptor 1 effector functions - JNK activation is not linked to apoptosis while NF-κ-B activation prevents cell death. Cell. 87:1996;565-576.
25. Natoli G., Costanzo A., Ianni A., Templeton D.J., Woodgett J.R., Balsano C., Levrero M. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science. 275:1997;200-203.
26. Marsters S.A., Sheridan J.P., Donahue C.J., Pitti R.M., Gray C.L., Goddard A.D., Bauer K.D., Ashkenazi A. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κ-B. Curr Biol. 6:1996;1669-1676.
27. Kitson J., Raven T., Jiang Y.P., Goeddel D.V., Giles K.M., Pun K.T., Grinham C.J., Brown R., Farrow S.N. A death-domain-containing receptor that mediates apoptosis. Nature. 384:1996;372-375.
28. Bodmer J.L., Burns K., Schneider P., Hofmann K., Steiner V., Thome M., Bornand T., Hahne M., Schröter M., Becker K., Wilson A., French L.E., Browning J.L., MacDonald H.R., Tschopp J. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (APO-1/CD95). Immunity. 6:1997;79-88.
29. Screaton G.R., Xu X.N., Olsen A.L., Cowper A.E., Tan R.S., McMichael A.J., Bell J.I. LARD - a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci USA. 94:1997;4615-4619.
30. Schneider P., Thome M., Burns K., Bodmer J.L., Hofmann K., Kataoka T., Holler N., Tschopp J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κ-B. Immunity. 7:1997;831-836.
31. Chaudhary P.M., Eby M., Jasmin A., Bookwalter A., Murray J., Hood L. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κ-B pathway. Immunity. 7:1997;821-830.
32. Shu H.B., Halpin D.R., Goeddel D.V. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity. 6:1997;751-763.
33. Irmler M., Thome M., Hahne M., Schneider P., Hofmann B., Steiner V., Bodmer J.L., Schröter M., Burns K., Mattmann C., Rimoldi D., French L.E., Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature. 388:1995;190-195.
34. Muzio M., Natoli G. The human Toll signaling pathway: Divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med. 187:1998;2097-2101.
35. Medzhitov R., Preston-Hurlburt P. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell. 2:1998;253-258.
36. Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.L., Dimarco F., French L., Tschopp J. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem. 273:1998;12203-12209.
37. Wesche H., Henzel W.J., Shillinglaw W., Li S., Cao Z.D. MyD88 - an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 7:1997;837-847.
38. Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D.V. TRAF6 is a signal transducer for interleukin-1. Nature. 383:1996;443-446.
39. Muzio M., Ni J., Feng P., Dixit V.M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 278:1997;1612-1615.
40. Ishida T.K., Tojo T., Aoki T., Kobayashi N., Ohishi T., Watanabe T., Yamamoto T., Inoue J. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci USA. 93:1996;9437-9442.
41. Nakano H., Oshima H., Chung W., Williams-Abbott L., Ware C.F., Yagita H., Okumura K. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J Biol Chem. 271:1996;14661-14664.
42. VanArsdale T.L., VanArsdale S.L., Force W.R., Walter B.N., Mosialos G., Kieff E., Reed J.C., Ware C.F. Lymphotoxin-β receptor signaling complex - role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κ-B. Proc Natl Acad Sci USA. 94:1997;2460-2465.
43. Ishida T., Mizushima S., Azuma S., Kobayashi N., Tojo T., Suzuki K., Aizawa S., Watanabe T., Mosialos G., Kieff E., Yamamoto T., Inoue J. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem. 271:1996;28745-28748.
44. Rothe M., Sarma V., Dixit V.M., Goeddel D.V. TRAF2-mediated activation of NF-κ B by TNF receptor 2 and CD40. Science. 269:1995;1424-1427.
45. Reinhard C., Shamoon B., Shyamala V., Williams L.T. Tumor necrosis factor α-induced activation of c-Jun N-terminal kinase is mediated by TRAF2. EMBO J. 16:1997;1080-1092.
46. Song H.Y., Regnier C.H., Kirschning C.J., Goeddel D.V., Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades - bifurcation of nuclear factor-κ-B and c-Jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci USA. 94:1997;9792-9796.
47. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3 K-related kinase involved in NF-κ-B induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544.
48. Baeuerle P.A., Baltimore D. NF-κ B: ten years after. Cell. 87:1996;13-20.
49. May M.J., Ghosh S. Signal transduction through NF-κ B. Immunol Today. 19:1998;80-88.
50. Kelliher M.A., Grimm S., Ishida Y., Kuo F., Stanger B.Z., Leder P. The death domain kinase RIP mediates the TNF-induced NF-κ-B signal. Immunity. 8:1998;297-303.
51. Lee S.Y., Reichlin A., Santana A., Sokol K.A., Nussenzweig M.C., Choi Y. TRAF2 is essential for JNK but not NF-κ-B activation and regulates lymphocyte proliferation and survival. Immunity. 7:1997;703-713.
52. Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., Delapompa J.L., Ferrick D., Hum B., Iscove N., Ohashi P., Rothe M., Goeddel D.V., Mak T.W. Early lethality, functional NF-κ-B activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity. 7:1997;715-725.
53. Beyaert R., Cuenda A., Vanden Berghe W., Plaisance S., Lee J.C., Haegeman G., Cohen P., Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15:1996;1914-1923.
54. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., Haegeman G. P38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor κ-B p65 transactivation mediated by tumor necrosis factor. J Biol Chem. 273:1998;3285-3290.
55. Bergmann M., Hart L., Lindsay M., Barnes P.J., Newton R. I-κ-B-α degradation and nuclear factor-κ-B DNA binding are insufficient for interleukin-1-β and tumor necrosis factor-α-induced κ-B-dependent transcription - requirement for an additional activation pathway. J Biol Chem. 273:1998;6607-6610.
56. Carpentier I., Declercq W., Malinin N.L., Wallach D., Fiers W., Beyaert R. TRAF2 plays a dual role in NF-κ-B-dependent gene activation by mediating the TNF-induced activation of p38 MAPK and I-κ-B kinase pathways. FEBS Lett. 425:1998;195-198.
57. Yuasa T., Ohno S., Kehrl J.H., Kyriakis J.M. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38 - germinal center kinase couples TRAF2 to mitogen-activated protein kinase/Erk kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J Biol Chem. 273:1998;22681-22692.
58. Shi C.S., Kehrl J.H. Activation of stress-activated protein kinase c-Jun N-terminal kinase, but not NF-κ-B, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway. J Biol Chem. 272:1997;32102-32107.
59. Hirano M., Osada S., Aoki T., Hirai S., Hosaka M., Inoue J., Ohno S. MEK kinase is involved in tumor necrosis factor α-induced NF-κB activation and degradation of IκB-α J Biol Chem. 271:1996;13234-13238.
60. Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M, Miyazono K, Ichijo H, Saitoh M, ASK1 is essential for JNK/SAPK activation by TRAF2, Mol Cell 2:389-395.
61. Ichijo H., Nishida E., Irie K., Tendijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 275:1997;90-94.
62. Chang H.Y., Nishitoh H., Yang X., Ichijo H., Baltimore D. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science. 281:1998;1860-1863.
63. Wu M., Lee H.Y., Bellas R.E., Schauer S.L., Arsura M., Katz D., Fitzgerald M.J., Rothstein T.L., Sherr D.H., Sonenshein G.E. Inhibition of NF-κ-B/rel induces apoptosis of murine B cells. EMBO J. 15:1996;4682-4690.
64. Beg A.A., Baltimore D. An essential role for NF-κ-B in preventing TNF-α-induced cell death. Science. 274:1996;782-784.
65. Wang C.Y., Mayo M.W., Baldwin A.S. TNF- and cancer therapy-induced apoptosis - potentiation by inhibition of NF-κ-B. Science. 274:1996;784-787.
66. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNF-α-induced apoptosis by NF-κ-B. Science. 274:1996;787-789.
67. Weiss T., Grell M., Siemienski K., Mühlenbeck F., Dürkop H., Pfizenmaier K., Scheurich P., Wajant H. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J Immunol. 161:1998;3136-3142.
68. Chu Z.L., McKinsey T.A., Liu L., Gentry J.J., Malim M.H., Ballard D.W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κ-B control. Proc Natl Acad Sci USA. 94:1997;10057-10062.
69. Roy N., Deveraux Q.L., Takahashi R., Salvesen G.S., Reed J.C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16:1997;6914-6925.
70. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. NF-κ-B antiapoptosis - induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1998;1680-1683.
71. Rothe M., Pan M.G., Henzel W.J., Ayres T.M., Goeddel D.V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83:1995;1243-1252.
72. Siemienski K., Peters N., Scheurich P., Wajant H. Organization of the human tumour necrosis factor receptor-associated factor 1 (TRAF1) gene and mapping to chromosome 9q33-34. Gene. 195:1997;35-39.
73. Speiser D.E., Lee S.Y., Wong B., Arron J., Santana A., Kong Y.Y., Ohashi P.S., Choi Y. A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J Exp Med. 185:1997;1777-1783.
74. Song H.Y., Rothe M., Goeddel D.V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc Natl Acad Sci USA. 93:1996;6721-6725.
75. Jäättelä M., Mouritzen H., Elling F., Bastholm L. A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol. 156:1996;1166-1173.
76. Zheng L., Fisher G., Miller R.E., Peschon J., Lynch D.H., Lenardo M.J. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 377:1995;348-351.
77. Speiser D.E., Sebzda E., Ohteki T., Bachmann M.F., Pfeffer K., Mak T.W., Ohashi P.S. Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur J Immunol. 26:1996;3055-3060.
78. Weiss T., Grell M., Hessabi B., Bourteele S., Müller G., Scheurich P., Wajant H. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80 - requirement of the TNF receptor-associated factor-2 binding site. J Immunol. 158:1997;2398-2404.
79. Declercq W., Denecker G., Fiers W., Vandenabeele P. Cooperation of both TNF receptors in inducing apoptosis - involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. J Immunol. 161:1998;390-399.
80. Duckett C.S., Thompson C.B. CD30-dependent degradation of TRAF2 - implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 11:1997;2810-2821.
81. Deveraux Q.L., Takahashi R., Salvesen G.S., Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:1997;300-304.
82. Duckett C.S., Gedrich R.W., Gilfillan M.C., Thompson C.B. Induction of nuclear factor κ-B by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol Cell Biol. 17:1997;1535-1542.
83. Cooper J.T., Stroka D.M., Brostjan C., Palmetshofer A., Bach F.H., Ferran C. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem. 271:1996;18068-18073.
84. Relaix F., Wei X.J., Wu X.W., Sassoon D.A. Peg3/pw1 is an imprinted gene involved in the TNF-NF-κ-B signal transduction pathway. Nat Genet. 18:1998;287-291.
85. Lee S.Y., Choi Y. TRAF-interacting protein (TRIP) - a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-κ-B activation. J Exp Med. 185:1997;1275-1285.
86. Saoulli K., Lee S.Y., Cannons J.L., Yeh W.C., Santana A., Goldstein M.D., Bangia N., Debenedette M.A., Mak T.W., Choi Y., Watts T.H. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J Exp Med. 187:1998;1849-1862.
87. Kuhne M.R., Robbins M., Hambor J.E., MacKey M.F., Kosaka Y., Nishimura T., Gigley J.P., Noelle R.J., Calderhead D.M. Assembly and regulation of the CD40 receptor complex in human B cells. J Exp Med. 186:1997;337-342.
88. Cheng G., Baltimore D. TANK, a co-inducer with TRAF2 of TNF- and CD40L-mediated NF-κB activation. Genes Dev. 10:1996;963-973.
89. Rothe M., Xiong J., Shu H.B., Williamson K., Goddard A., Goeddel D.V. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc Natl Acad Sci USA. 93:1996;8241-8246.
90. Regnier C.H., Tomasetto C., Moog-Lutz C., Chenard M.P., Wendling C., Basset P., Rio M.C. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J Biol Chem. 270:1995;25715-25721.
91. Masson R., Regnier C.H., Chenard M.P., Wendling C., Mattei M.G., Tomasetto C., Rio M.C. Tumor necrosis factor receptor associated factor 4 (TRAF4) expression pattern during mouse development. Mech Dev. 71:1998;187-191.
92. Krajewska M., Krajewski S., Zapata J.M., VanArsdale T., Gascoyne R.D., Berern K., McFadden D., Shabaik A., Hugh J., Reynolds C., Clevenger C.V., Reed J.C. TRAF-4 expression in epithelial progenitor cells - analysis in normal adult, fetal, and tumor tissues. Am J Pathol. 152:1998;1549-1561.
93. Xu Y., Cheng G.H., Baltimore D. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity. 5:1996;407-415.
94. Fennewald S., van Santen V. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J Virol. 51:1984;411-419.
95. Hennessy K., Fennewald S. A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc Natl Acad Sci USA. 81:1984;7207-7211.
96. Kaye K.M., Devergne O., Harada J.N., Izumi K.M., Yalamanchili R., Kieff E., Mosialos G. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-κ B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc Natl Acad Sci USA. 93:1996;11085-11090.
97. Huen D.S., Henderson S.A., Croom-Carter D., Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κ B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene. 10:1995;549-560.
98. Izumi K.M., Kaye K.M., Kieff E.D. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc Natl Acad Sci USA. 94:1997;1447-1452.
99. Mitchell T., Sugden B. Stimulation of NF-κ B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J Virol. 69:1995;2968-2976.
100. Floettmann J.E., Rowe M. Epstein-Barr-virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-κ-B activation. Oncogene. 15:1997;1851-1858.
101. Izumi K.M., Kieff E.D. The Epstein-Barr-virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κ-B. Proc Natl Acad Sci USA. 94:1997;12592-12597.
102. Sylla B.S., Hung S.C., Davidson D.M., Hatzivassiliou E., Malinin N.L., Wallach D., Gilmore T.D., Kieff E., Mosialos G. Epstein-Barr-virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-κ-B through a pathway that includes the NF-κ-B-inducing kinase and the I-κ-B kinases IKK-α and IKK-β Proc Natl Acad Sci USA. 95:1998;10106-10111.
103. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:1995;389-399.
104. Song H.Y., Donner D.B. Association of a RING finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptor. Biochem J. 309:1995;825-829.
105. Hu H.M., O'Rourke K., Boguski M.S., Dixit V.M. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem. 269:1994;30069-30072.
106. Sato T., Irie S., Reed J.C. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358:1995;113-118.
107. Mizushima S., Fujita M., Ishida T., Azuma S., Kato K., Hirai M., Otsuka M., Yanamoto T., Inoue J. Cloning and characterization of a cDNA encoding the human homolog of tumor necrosis factor receptor-associated factor 5 (TRAF5). Gene. 207:1998;135-140.
108. Lee S.Y., Park C.G., Choi Y. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J Exp Med. 183:1996;669-674.
109. Kawamata S., Hori T., Imura A., Takaorikondo A., Uchiyama T. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF)2- and TRAF5-mediated NF-κ-B activation. J Biol Chem. 273:1998;5808-5814.
110. Marsters S.A., Ayres T.M., Skubatch M., Gray C.L., Rothe M., Ashkenazi A. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-κ-B and AP-1. J Biol Chem. 272:1997;14029-14032.
111. Wong B.R., Josien R., Lee S.Y., Vologodskaia M., Steinman R.M., Choi Y. The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor. J Biol Chem. 273:1998;28355-28359.
112. Hsu H., Huang J., Shu H.B., Baichwal V., Goeddel D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity. 4:1996;387-396.
113. Thome M., Hofmann K., Burns K., Martinon F., Bodmer J.L., Mattmann C., Tschopp J. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr Biol. 8:1998;885-888.
114. McCarthy J.V., Ni J., Dixit V.M. RIP2 is a novel NF-κ-B-activating and cell death-inducing kinase. J Biol Chem. 273:1998;16968-16975.